Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. More Details
Imperfect balance sheet with weak fundamentals.
Share Price & News
How has Blonder Tongue Laboratories's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: BDR's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: BDR exceeded the US Communications industry which returned -14% over the past year.
Return vs Market: BDR exceeded the US Market which returned 18.3% over the past year.
Price Volatility Vs. Market
How volatile is Blonder Tongue Laboratories's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall StIs Blonder Tongue Laboratories (NYSEMKT:BDR) A Risky Investment?
4 months ago | Simply Wall StThe Blonder Tongue Laboratories (NYSEMKT:BDR) Share Price Is Down 46% So Some Shareholders Are Getting Worried
7 months ago | Simply Wall StDoes Blonder Tongue Laboratories, Inc. (NYSEMKT:BDR) Have A Particularly Volatile Share Price?
Is Blonder Tongue Laboratories undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate BDR's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate BDR's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: BDR is unprofitable, so we can't compare its PE Ratio to the US Communications industry average.
PE vs Market: BDR is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate BDR's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: BDR is overvalued based on its PB Ratio (3.2x) compared to the US Communications industry average (1.7x).
How is Blonder Tongue Laboratories forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Tech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Blonder Tongue Laboratories has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Take a look at our analysis of BDR’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- Blonder Tongue Laboratories competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Tech industry.
How has Blonder Tongue Laboratories performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: BDR is currently unprofitable.
Growing Profit Margin: BDR is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: BDR is unprofitable, but has reduced losses over the past 5 years at a rate of 19% per year.
Accelerating Growth: Unable to compare BDR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BDR is unprofitable, making it difficult to compare its past year earnings growth to the Communications industry (-28.9%).
Return on Equity
High ROE: BDR has a negative Return on Equity (-196.51%), as it is currently unprofitable.
How is Blonder Tongue Laboratories's financial position?
Financial Position Analysis
Short Term Liabilities: BDR's short term assets ($10.9M) exceed its short term liabilities ($7.4M).
Long Term Liabilities: BDR's short term assets ($10.9M) exceed its long term liabilities ($4.9M).
Debt to Equity History and Analysis
Debt Level: BDR's debt to equity ratio (70.9%) is considered high.
Reducing Debt: BDR's debt to equity ratio has increased from 59.2% to 70.9% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BDR has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BDR has less than a year of cash runway if free cash flow continues to reduce at historical rates of 48.3% each year
What is Blonder Tongue Laboratories's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate BDR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BDR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if BDR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BDR's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of BDR's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ted Grauch (54 yo)
Mr. Edward Rowland Grauch, also known as Ted, has been the Chief Executive Officer at Blonder Tongue Laboratories, Inc. since January 1, 2020. Mr. Grauch has been the President of Blonder Tongue Laboratori ...
CEO Compensation Analysis
Compensation vs Market: Ted's total compensation ($USD323.98K) is below average for companies of similar size in the US market ($USD578.04K).
Compensation vs Earnings: Ted's compensation has been consistent with company performance over the past year.
|President & CEO||0.75yr||US$323.98k||2.96% |
|Senior VP||19.42yrs||US$278.84k||0.16% |
|Senior Vice President of Operations||0.75yr||US$249.50k||0.81% |
|Senior VP of Engineering & CTO||2.25yrs||US$285.78k||0.29% |
|MD of Strategic Accounts & Director||27.08yrs||US$534.32k||28.04% |
Experienced Management: BDR's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
|MD of Strategic Accounts & Director||27.08yrs||US$534.32k||28.04% |
|Independent Director||12.67yrs||US$59.54k||2.43% |
|Independent Director||22.83yrs||US$50.67k||2.92% |
|Independent Director||27.08yrs||US$55.54k||2.36% |
|Independent Director||5.67yrs||US$50.54k||4.44% |
|Independent Director||2.75yrs||US$59.64k||0.83% |
|Independent Chairman||5.42yrs||US$90.14k||6.63% |
|Independent Director||9.08yrs||US$63.28k||2.81% |
|Independent Director||0.75yr||no data||no data|
|Independent Director||0.33yr||no data||no data|
|Independent Director||0.17yr||no data||0.10% |
Experienced Board: BDR's board of directors are considered experienced (5.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Blonder Tongue Laboratories, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Blonder Tongue Laboratories, Inc.
- Ticker: BDR
- Exchange: AMEX
- Founded: 1950
- Industry: Communications Equipment
- Sector: Tech
- Market Cap: US$13.575m
- Shares outstanding: 9.77m
- Website: https://www.blondertongue.com
Number of Employees
- Blonder Tongue Laboratories, Inc.
- One Jake Brown Road
- Old Bridge
- New Jersey
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|BDR||AMEX (NYSE MKT LLC)||Yes||Common Stock||US||USD||Dec 1995|
Blonder Tongue Laboratories, Inc., a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the Unite ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/26 00:43|
|End of Day Share Price||2020/10/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.